ResMed Inc. Peer Comparison
Metric | Value | Ranking | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $36.8 Billion | 2/11 | BDX $68.1B |
RMD $36.8B |
COO $21.7B |
WST $21.6B |
BAX $20.1B |
HOLX $18.7B |
TFX $11.4B |
MMSI $5.6B |
ICUI $4.3B |
STAA $1.5B |
EMBC $908.2M |
Gross Margin | 58% | 4/11 | STAA 79% |
EMBC 69% |
COO 61% |
RMD 58% |
HOLX 56% |
TFX 56% |
MMSI 47% |
BDX 46% |
BAX 36% |
ICUI 35% |
WST 33% |
Profit Margin | 24% | 1/11 | RMD 24% |
HOLX 19% |
WST 16% |
TFX 11% |
MMSI 11% |
BDX 10% |
COO 10% |
STAA 7% |
EMBC 5% |
ICUI -4% |
BAX -8% |
EBITDA margin | 31% | 3/11 | EMBC 34% |
HOLX 33% |
RMD 31% |
COO 28% |
BDX 26% |
TFX 26% |
WST 24% |
MMSI 21% |
BAX 17% |
STAA 14% |
ICUI 13% |
Quarterly Revenue | $1.2 Billion | 3/11 | BDX $5.0B |
BAX $3.8B |
RMD $1.2B |
HOLX $1.0B |
COO $1.0B |
TFX $749.7M |
WST $702.0M |
ICUI $595.8M |
MMSI $337.6M |
EMBC $272.5M |
STAA $99.0M |
Quarterly Earnings | $292.2 Million | 2/11 | BDX $487.0M |
RMD $292.2M |
HOLX $194.5M |
WST $111.3M |
COO $104.7M |
TFX $80.0M |
MMSI $35.7M |
EMBC $14.7M |
STAA $7.4M |
ICUI -$21.4M |
BAX -$314.0M |
Quarterly Free Cash Flow | $415.2 Million | 2/11 | BDX $1.1B |
RMD $415.2M |
HOLX $361.9M |
COO $118.5M |
WST $64.8M |
ICUI $60.1M |
MMSI $57.2M |
TFX $56.5M |
BAX -$1.0M |
EMBC -$11.8M |
STAA -$16.6M |
Trailing 4 Quarters Revenue | $4.5 Billion | 3/11 | BDX $19.8B |
BAX $15.0B |
RMD $4.5B |
HOLX $3.3B |
TFX $3.0B |
WST $2.9B |
COO $2.9B |
ICUI $2.3B |
MMSI $1.3B |
EMBC $1.1B |
STAA $252.7M |
Trailing 4 Quarters Earnings | $1.0 Billion | 3/11 | BDX $5.0B |
BAX $3.8B |
RMD $1.2B |
HOLX $1.0B |
COO $1.0B |
TFX $749.7M |
WST $702.0M |
ICUI $595.8M |
MMSI $337.6M |
EMBC $272.5M |
STAA $99.0M |
Quarterly Earnings Growth | 27% | 3/11 | HOLX 580% |
MMSI 76% |
RMD 27% |
COO 23% |
STAA 22% |
BDX 20% |
EMBC -3% |
TFX -28% |
WST -28% |
ICUI -115% |
BAX -123% |
Annual Earnings Growth | 10% | 6/11 | BAX 27611% |
COO 76% |
MMSI 43% |
EMBC 22% |
HOLX 14% |
RMD 10% |
WST -9% |
STAA -17% |
BDX -18% |
TFX -23% |
ICUI -80% |
Quarterly Revenue Growth | 9% | 1/11 | RMD 9% |
COO 8% |
ICUI 8% |
STAA 7% |
MMSI 5% |
HOLX 3% |
BAX 3% |
BDX 2% |
TFX 1% |
EMBC -5% |
WST -7% |
Annual Revenue Growth | 2% | 4/11 | MMSI 7% |
TFX 5% |
BDX 3% |
RMD 2% |
BAX 2% |
ICUI 2% |
EMBC 0% |
WST -1% |
COO -19% |
STAA -19% |
HOLX -20% |
Cash On Hand | $238.4 Million | 9/11 | BDX $4.5B |
HOLX $2.4B |
BAX $2.1B |
MMSI $638.7M |
WST $446.2M |
ICUI $302.6M |
EMBC $281.8M |
TFX $238.6M |
RMD $238.4M |
STAA $192.8M |
COO $109.9M |
Short Term Debt | $35.2 Million | 8/11 | BAX $2.5B |
BDX $1.2B |
WST $154.1M |
TFX $93.8M |
ICUI $69.9M |
COO $40.8M |
HOLX $40.7M |
RMD $35.2M |
EMBC $17.8M |
MMSI $11.7M |
STAA $4.8M |
Long Term Debt | $838.8 Million | 8/11 | BDX $18.1B |
BAX $10.4B |
COO $2.6B |
HOLX $2.5B |
TFX $1.6B |
EMBC $1.6B |
ICUI $1.6B |
RMD $838.8M |
MMSI $801.3M |
WST $72.9M |
STAA $31.5M |
PE | 36.08 | 7/11 | STAA 124.89 |
COO 60.34 |
MMSI 47.58 |
BDX 46.65 |
TFX 43.39 |
WST 41.11 |
RMD 36.08 |
HOLX 26.63 |
EMBC 13.03 |
BAX 8.11 |
ICUI -1.00 |
PS | 8.10 | 1/11 | RMD 8.10 |
COO 7.55 |
WST 7.50 |
STAA 5.83 |
HOLX 5.74 |
MMSI 4.29 |
TFX 3.80 |
BDX 3.43 |
ICUI 1.85 |
BAX 1.34 |
EMBC 0.81 |
PB | 7.57 | 2/11 | WST 8.37 |
RMD 7.57 |
MMSI 4.36 |
HOLX 3.77 |
STAA 3.60 |
COO 2.74 |
BDX 2.63 |
BAX 2.61 |
TFX 2.51 |
ICUI 2.09 |
EMBC 0.00 |
PC | 154.54 | 2/11 | COO 197.27 |
RMD 154.54 |
WST 48.36 |
TFX 47.94 |
BDX 15.17 |
ICUI 14.06 |
BAX 9.59 |
MMSI 8.75 |
HOLX 7.66 |
STAA 7.65 |
EMBC 3.22 |
Liabilities to Equity | 0.41 | 8/11 | BAX 2.43 |
BDX 1.15 |
ICUI 1.10 |
MMSI 0.85 |
HOLX 0.80 |
TFX 0.63 |
COO 0.53 |
RMD 0.41 |
WST 0.35 |
STAA 0.25 |
EMBC 0.00 |
ROA | 0.15 | 1/11 | RMD 15% | WST 15% | BAX 9% | HOLX 8% | MMSI 5% | EMBC 5% | TFX 4% | BDX 3% | COO 3% | STAA 2% | ICUI -2% |
ROE | 0.21 | 2/11 | BAX 32% |
RMD 21% |
WST 20% |
HOLX 14% |
MMSI 9% |
BDX 6% |
TFX 6% |
COO 5% |
STAA 3% |
ICUI -3% |
EMBC -9% |
Current Ratio | 3.42 | 3/11 | STAA 4.95 |
WST 3.82 |
RMD 3.42 |
COO 2.89 |
TFX 2.58 |
HOLX 2.26 |
MMSI 2.18 |
ICUI 1.91 |
BDX 1.87 |
BAX 1.41 |
EMBC 0.62 |
Quick Ratio | 0.12 | 8/11 | STAA 124.89 |
COO 60.34 |
MMSI 47.58 |
BDX 46.65 |
TFX 43.39 |
WST 41.11 |
RMD 36.08 |
HOLX 26.63 |
EMBC 13.03 |
BAX 8.11 |
ICUI -1.00 |
Long Term Debt to Equity | 0.17 | 8/11 | BAX} 1.37 |
ICUI} 0.76 |
BDX} 0.70 |
MMSI} 0.62 |
HOLX} 0.51 |
TFX} 0.36 |
COO} 0.33 |
RMD} 0.17 |
STAA} 0.08 |
WST} 0.03 |
EMBC} -2.08 |
Debt to Equity | 0.18 | 8/11 | BAX 1.75 |
ICUI 0.82 |
BDX 0.75 |
MMSI 0.68 |
HOLX 0.52 |
TFX 0.40 |
COO 0.33 |
RMD 0.18 |
WST 0.12 |
STAA 0.09 |
EMBC -2.16 |
Burn Rate | -0.95 | 7/11 | TFX 28.51 |
COO 12.14 |
BDX 8.37 |
EMBC 5.28 |
ICUI 2.99 |
BAX 1.55 |
RMD -0.95 |
WST -6.39 |
HOLX -29.00 |
STAA -39.14 |
MMSI -866.16 |
Cash to Cap | 0.01 | 10/11 | EMBC 0.31 |
HOLX 0.13 |
STAA 0.13 |
MMSI 0.11 |
BAX 0.10 |
BDX 0.07 |
ICUI 0.07 |
TFX 0.02 |
WST 0.02 |
RMD 0.01 |
COO 0.01 |
CCR | 1.42 | 4/11 | BDX 2.23 |
HOLX 1.86 |
MMSI 1.60 |
RMD 1.42 |
COO 1.13 |
TFX 0.71 |
WST 0.58 |
BAX 0.00 |
EMBC -0.80 |
STAA -2.26 |
ICUI -2.81 |
EV to EBITDA | 98.30 | 2/11 | WST} 126.38 |
RMD} 98.30 |
STAA} 98.19 |
COO} 85.98 |
MMSI} 80.27 |
ICUI} 72.09 |
TFX} 67.02 |
BDX} 64.62 |
HOLX} 55.92 |
BAX} 49.43 |
EMBC} 24.56 |
EV to Revenue | 8.24 | 2/11 | COO 8.43 |
RMD 8.24 |
WST 7.46 |
HOLX 5.78 |
STAA 5.21 |
MMSI 4.47 |
TFX 4.33 |
BDX 4.18 |
ICUI 2.45 |
BAX 2.09 |
EMBC 2.04 |